Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 11/06/2024 9:48:45 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 12057
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
68715
GSK Phase 2 Otilimab fails to meet Primary end
crashco
02/25/2021 2:33:35 PM
68713
Hi Jim, the User who authored that post is
BooDog
02/25/2021 11:10:50 AM
68712
admins over there must be making bank deleting
(1)
BooDog
02/25/2021 10:51:17 AM
68709
Here is a post by JFM on IFUD this morning that
(11)
falcon74
02/24/2021 5:11:33 PM
68707
I don't think uplisting is what will cut down on
(8)
petemantx
02/24/2021 3:56:18 PM
68706
I cant wait until we up-list. The manipulation
(4)
stocker11
02/24/2021 3:48:07 PM
68705
Remember that some time ago it was mentioned
(3)
Drano
02/24/2021 11:49:25 AM
68704
That is good to know as it seems it has taken
(2)
petemantx
02/24/2021 11:21:14 AM
68703
Agree , only posted that link to show what other
NotRichYet2
02/24/2021 9:57:07 AM
68702
Unlike the vaccines that require a specialized
(8)
Drano
02/24/2021 9:37:46 AM
68701
Kind of like predicting a car's time at the drag
(5)
petemantx
02/24/2021 9:35:44 AM
68700
Makes me also wonder if the foreign part of the
(3)
petemantx
02/24/2021 9:22:42 AM
68698
Here is a computerized ANALISIS of IPIX's
(1)
NotRichYet2
02/24/2021 8:27:13 AM
68696
Why is the phII trial not on clinicaltrials . gov
kerdom
02/24/2021 8:14:44 AM
68695
Awesome post Mo! I see it playing out pretty much
(5)
Ultimate
02/24/2021 7:31:35 AM
68693
My opinion on the number of B-CV19 trials is as
(20)
Mo
02/24/2021 1:11:57 AM
68692
I agree that Leo has missed a few PR
(1)
thefamilyman
02/24/2021 12:57:59 AM
68691
Leo put out quite a few PRs last year. Many some
(2)
Commando911
02/23/2021 11:47:56 PM
68690
Thank-you Pete, as usual a killer
angeli
02/23/2021 10:47:57 PM
68688
My take on "the market" is that retail are pawns
(11)
petemantx
02/23/2021 7:10:01 PM
68686
Speculation: I am also intrigued by the word
(4)
doubleJ23
02/23/2021 1:23:51 PM
68685
Ive been checking that site regularly.
Patchesohoulihan
02/23/2021 11:21:13 AM
68682
"it wont be long before we hear something."
(7)
farrell
02/23/2021 10:54:06 AM
68681
Don't get all hung up trying to parse language.
(4)
Drano
02/23/2021 10:23:05 AM
68680
Like I mentioned before, I also want additional
(6)
Ultimate
02/23/2021 10:10:32 AM
68678
Hi all, I'm trying to do some DD and see if there
(2)
doubleJ23
02/23/2021 9:46:24 AM
68675
A good and respected friend sent me this note
(10)
petemantx
02/22/2021 8:19:20 PM
68674
My take on todays events and 10-Q filing is
(13)
Mo
02/22/2021 5:47:17 PM
68673
I think the FDA is going to be trying very hard
(5)
Drano
02/22/2021 4:42:33 PM
68672
Just saw Fauci giving an update with a lot of
(4)
Chemdeps
02/22/2021 4:03:31 PM
68671
With the amount of people needed to fill the 120
(2)
petemantx
02/22/2021 3:56:07 PM
68670
Thats exactly as I see it. We are out of 1st
(2)
Ultimate
02/22/2021 3:00:50 PM
68669
Last week there was a document that showed 17, so
Drano
02/22/2021 2:48:13 PM
68668
Drano......I agree that common sense would tell
(1)
falcon74
02/22/2021 2:10:23 PM
68667
There are 17 clinical trial sites in Russia. I
(1)
Drano
02/22/2021 1:38:59 PM
68666
Chem---- I completely agree with your
(5)
falcon74
02/22/2021 1:04:10 PM
68665
I thought the statement that the phase II trials
(3)
Chemdeps
02/22/2021 12:52:08 PM
68664
Pete From the AS agreement. (i) Development
(3)
bettingbig
02/22/2021 12:18:54 PM
68663
Here's a list of "highlights" from the 10Q that I
(6)
Drano
02/22/2021 12:02:10 PM
68661
Is a successful P1 by AS considered a milestone
(1)
petemantx
02/22/2021 11:50:58 AM
68659
A little something MORE to look forward to.
(4)
NotRichYet2
02/22/2021 11:45:20 AM
68658
Excellent news! I thought covid impacted the
(7)
Ultimate
02/22/2021 11:44:47 AM
68657
"The Company is collaborating with a Regional
(10)
Drano
02/22/2021 11:44:07 AM
68656
10Q great news: " In January 2021, Alfasigma
(10)
Drano
02/22/2021 11:41:44 AM
68654
A phase2/3 or 3 wouldnt be possible if there
(2)
Ultimate
02/22/2021 11:19:04 AM
68651
Perhaps they are testing for other viruses also.
Fit007
02/22/2021 10:02:20 AM
68643
Maybe a ph3 with EUA in Russia. One can wonder.
(1)
zdubble17
02/22/2021 9:34:35 AM
68641
Thanks. That's one hell of an extension to end
(1)
crashco
02/22/2021 9:28:25 AM
68640
https://clinline.ru/reestr-klinicheskih-issledova
zdubble17
02/22/2021 9:26:02 AM
68638
I believe the trial has been extended
(1)
zdubble17
02/22/2021 9:24:57 AM
Newer
Older
Recent Articles
Hydreight Technologies Achieves Major Revenue Growth in Q3
Legal Investigations Alert: Shareholder Rights and Actions
NOVONIX Set to Shine at December Investor Engagements
Montfort Capital Reports Q3 Financials and Divestment Plan
Understanding Distribution Sources of Cohen & Steers Fund (RNP)
Exploring the Innovative Landscape of Cannabis with High Science
Understanding Cohen & Steers Total Return Realty Fund Distributions
Investment Insights from Cohen & Steers Opportunity Fund
Xerox Holdings Corporation: Investigating Investor Claims and Losses
Investigation Notice: Humacyte Investors Should Act Now
Fusion Fuel's Strategic Acquisition and Leadership Transition
Rivalry Corp. Announces Successful Non-Brokered Placement Raise
Cohen & Steers Infrastructure Fund Updates Distribution Insights
Growth Surge in Voice Evacuation Systems: A 1.1 Billion Leap
FIBRA Prologis Completes Tender Offer for Terrafina CBFIs
Understanding Distribution Sources for Cohen & Steers Realty Fund
Marpai Secures New Clients and Prepares for 2025 Growth
Lumina Gold's New Exploitation Contract Marks a Milestone
Goldman Sachs Shares Hedging Strategies for 2025 Market Risks
WattEV Advances EV Charging with New Rapid-Charging Standards
DIRTT Environmental Solutions Welcomes Holly Hess Groos
Mondee Faces Nasdaq Compliance Challenge Amid Leadership Changes
Teamsters Union Grows as FreshPoint Drivers Take a Stand
Challenges of Cannabis Legalization: Insights from Berlin's Justice Senator
TerrAscend Elevates Lynn Gefen to Chief People Officer Role
Maximus Inc Faces Uncertainty After Contract Cancellation
Kentucky's New Medical Cannabis Licenses Create Excitement
Franklin Templeton Updates Investors on ETF Liquidation Plans
Peoples Financial Corporation Announces Cash and Special Dividends
Lilium N.V. Investors: Key Opportunities in Lawsuit Leadership
S&W Seed Company Releases First Quarter 2025 Financials
Pond Technologies Expands Market Reach with Q3 Financial Filing
HP Inc. Reports Robust Q4 Results Amidst Stock Fluctuation
Gran Tierra Energy's New Oil Discovery and Strategic Partnership
Transforming the Events Industry: Rhuna Partners with Plume
ANI Pharmaceuticals Prepares for Piper Sandler Healthcare Conference
Ultragenyx Pharmaceutical's Upcoming Investor Conferences in December
Exela Technologies Outlines Plans for Upcoming Earnings Call
Cansortium Expands Financial Flexibility with New Credit Deal
Aclaris Therapeutics to Showcase Innovations at Major Conference
YXT.com Unveils Key Leadership Changes to Drive Growth
Mazarin Inc. Welcomes New CFO Amid Strategic Changes
Mazarin Inc. Grants Stock Options to Enhance Share Value
Autodesk Delivers Impressive Q3 Earnings Report
Nutanix Reports Strong Q1 Earnings Performance and Growth
Urbanfund Corp. Reports Impressive Financial Performance
Ambarella Inc Achieves Impressive Q3 Results, Stock Rises
Yelp Acquires RepairPal for Strategic Expansion in Services
TechTarget's Merger with Informa: A Game-Changer in B2B
Onco360 Partners with BrightSpring for Innovative Cancer Therapies